These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 8564706
1. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells. McKiel V, Gu Z, Wainberg MA, Hiscott J. J Interferon Cytokine Res; 1995 Oct; 15(10):849-55. PubMed ID: 8564706 [Abstract] [Full Text] [Related]
3. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Yang SS, Fliakas-Boltz V, Bader JP, Buckheit RW. Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321 [Abstract] [Full Text] [Related]
4. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro. Chong KT, Pagano PJ, Hinshaw RR. Antimicrob Agents Chemother; 1994 Feb; 38(2):288-93. PubMed ID: 7514857 [Abstract] [Full Text] [Related]
5. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. Wu S, Liu X, Solorzano MM, Kwock R, Avramis VI. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan 01; 8(1):1-9. PubMed ID: 8548339 [Abstract] [Full Text] [Related]
6. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection. Lambert DM, Bartus H, Fernandez AV, Bratby-Anders C, Leary JJ, Dreyer GB, Metcalf BW, Petteway SR. Antiviral Res; 1993 Aug 01; 21(4):327-42. PubMed ID: 7692816 [Abstract] [Full Text] [Related]
9. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS. J Exp Med; 1991 Mar 01; 173(3):589-97. PubMed ID: 1705278 [Abstract] [Full Text] [Related]
10. Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate. Chou TC, Zhu QY, Stein CA. AIDS Res Hum Retroviruses; 1991 Nov 01; 7(11):943-51. PubMed ID: 1760231 [Abstract] [Full Text] [Related]
11. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells. Rooke R, Tremblay M, Wainberg MA. Virology; 1990 May 01; 176(1):205-15. PubMed ID: 1691885 [Abstract] [Full Text] [Related]
12. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains. Zhu QY, Scarborough A, Polsky B, Chou TC. AIDS Res Hum Retroviruses; 1996 Apr 10; 12(6):507-17. PubMed ID: 8679306 [Abstract] [Full Text] [Related]
16. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. Selvam MP, Blay RA, Geyer S, Buck SM, Pollock L, Mayner RE, Epstein JS. AIDS Res Hum Retroviruses; 1993 May 10; 9(5):475-81. PubMed ID: 7686387 [Abstract] [Full Text] [Related]
17. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains. Mayers DL, Mikovits JA, Joshi B, Hewlett IK, Estrada JS, Wolfe AD, Garcia GE, Doctor BP, Burke DS, Gordon RK. Proc Natl Acad Sci U S A; 1995 Jan 03; 92(1):215-9. PubMed ID: 7816820 [Abstract] [Full Text] [Related]
18. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages. Mankertz J, von Baeyer H, Rokos K, Nündel M, Pauli G, Riedel E. Int J Clin Pharmacol Ther; 1995 Feb 03; 33(2):85-8. PubMed ID: 7757316 [Abstract] [Full Text] [Related]
19. Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement. Anand R, Nayyar S, Galvin TA, Merril CR, Bigelow LB. AIDS Res Hum Retroviruses; 1990 May 03; 6(5):679-89. PubMed ID: 1694454 [Abstract] [Full Text] [Related]